Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA grants orphan drug designation to PPL's AAT for congenital deficiency

June 16, 1999

Schering-Plough prepares potent H3 antagonists for allergy, CNS disorders, etc.

June 16, 1999

Chemokine peptides designed at NeoRx useful for inflammatory disorders

June 15, 1999

Antiallergic phenothiazines patented by Eisai investigators

June 15, 1999

Array BioPharma designs series of potent and selective tryptase inhibitors

June 14, 1999

Effects of macrolide antibiotics on IL-8 release by eosinophils in asthma

June 14, 1999

Amgen reveals potent and selective typtase-inhibitory series

June 11, 1999

Cystic Fibrosis Foundation awards research grant to Genzyme

June 10, 1999

FDA says 3M's inhaled corticosteroid in CFC-free inhaler approvable for asthma

June 7, 1999

Kyowa Hakko presents new phosphodiesterase inhibitors

June 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...